RIGEL PHARMACEUTICALS, INC. Operating Income
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Operating Income of $23.57 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was $23.57M, a 61.42% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was $11.88M, a 6.95% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was $23.17M, a 39.12% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was $28.42M, a 102.19% increase year-over-year.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was $125.47M, a 418.63% increase from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was $24.19M.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$20.49M.
- RIGEL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$55.55M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.57M 10-Q · filed 2026-08-04 | $35.46M 10-Q · filed 2026-08-04 | $58.63M derived: sum of 3 quarters · filed 2026-08-04 | $87.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $11.88M 10-Q · filed 2026-05-05 | $35.05M derived: sum of 2 quarters · filed 2026-05-05 | $63.48M derived: sum of 3 quarters · filed 2026-05-05 | $124.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $23.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $51.59M derived: sum of 2 quarters · filed 2026-03-03 | $112.69M derived: sum of 3 quarters · filed 2026-08-04 | $125.47M 10-K · filed 2026-03-03 |
| 2025-09-30 | $28.42M 10-Q · filed 2025-11-04 | $89.52M derived: sum of 2 quarters · filed 2026-08-04 | $102.30M 10-Q · filed 2025-11-04 | $118.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $61.10M 10-Q · filed 2026-08-04 | $73.88M 10-Q · filed 2026-08-04 | $90.53M derived: sum of 3 quarters · filed 2026-08-04 | $104.59M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $12.77M 10-Q · filed 2026-05-05 | $29.43M derived: sum of 2 quarters · filed 2026-05-05 | $43.48M derived: sum of 3 quarters · filed 2026-05-05 | $43.93M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $30.71M derived: sum of 2 quarters · filed 2026-03-03 | $31.16M derived: sum of 3 quarters · filed 2026-03-03 | $24.19M 10-K · filed 2026-03-03 |
| 2024-09-30 | $14.06M 10-Q · filed 2025-11-04 | $14.50M derived: sum of 2 quarters · filed 2025-11-04 | $7.54M 10-Q · filed 2025-11-04 | $9.50M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $447.00K 10-Q · filed 2025-08-05 | -$6.52M 10-Q · filed 2025-08-05 | -$4.55M derived: sum of 3 quarters · filed 2026-03-03 | -$9.02M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$6.97M 10-Q · filed 2025-05-06 | -$5.00M derived: sum of 2 quarters · filed 2026-03-03 | -$9.46M derived: sum of 3 quarters · filed 2026-03-03 | -$14.73M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.50M derived: sum of 2 quarters · filed 2026-03-03 | -$7.77M derived: sum of 3 quarters · filed 2026-03-03 | -$20.49M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$4.46M 10-Q · filed 2024-11-07 | -$9.73M derived: sum of 2 quarters · filed 2024-11-07 | -$22.46M 10-Q · filed 2024-11-07 | -$20.38M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$5.27M 10-Q · filed 2024-08-06 | -$17.99M 10-Q · filed 2024-08-06 | -$15.91M derived: sum of 3 quarters · filed 2025-03-04 | -$34.32M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | -$12.72M 10-Q · filed 2024-05-07 | -$10.65M derived: sum of 2 quarters · filed 2025-03-04 | -$29.05M derived: sum of 3 quarters · filed 2025-03-04 | -$42.01M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$16.32M derived: sum of 2 quarters · filed 2025-03-04 | -$29.29M derived: sum of 3 quarters · filed 2025-03-04 | -$55.55M 10-K · filed 2025-03-04 |
| 2022-09-30 | -$18.40M 10-Q · filed 2023-11-07 | -$31.37M derived: sum of 2 quarters · filed 2023-11-07 | -$57.63M 10-Q · filed 2023-11-07 | -$79.05M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$12.96M 10-Q · filed 2023-08-01 | -$39.23M 10-Q · filed 2023-08-01 | -$60.64M derived: sum of 3 quarters · filed 2024-03-05 | -$80.43M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$26.26M 10-Q · filed 2023-05-02 | -$47.68M derived: sum of 2 quarters · filed 2024-03-05 | -$67.46M derived: sum of 3 quarters · filed 2024-03-05 | -$80.51M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$21.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$41.20M derived: sum of 2 quarters · filed 2024-03-05 | -$54.25M derived: sum of 3 quarters · filed 2024-03-05 | -$12.50M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$19.79M 10-Q · filed 2022-11-03 | -$32.83M derived: sum of 2 quarters · filed 2022-11-03 | $8.92M 10-Q · filed 2022-11-03 | -$9.90M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$13.05M 10-Q · filed 2022-08-02 | $28.71M 10-Q · filed 2022-08-02 | $9.88M derived: sum of 3 quarters · filed 2023-03-07 | -$3.90M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $41.76M 10-Q · filed 2022-05-03 | $22.93M derived: sum of 2 quarters · filed 2023-03-07 | $9.15M derived: sum of 3 quarters · filed 2023-03-07 | -$8.24M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$18.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$32.61M derived: sum of 2 quarters · filed 2023-03-07 | -$50.00M derived: sum of 3 quarters · filed 2023-03-07 | -$28.97M 10-K · filed 2023-03-07 |
| 2020-09-30 | -$13.78M 10-Q · filed 2021-11-02 | -$31.17M derived: sum of 2 quarters · filed 2021-11-02 | -$10.15M 10-Q · filed 2021-11-02 | -$27.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$17.39M 10-Q · filed 2021-08-03 | $3.63M 10-Q · filed 2021-08-03 | -$13.70M derived: sum of 3 quarters · filed 2022-03-01 | -$25.74M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $21.03M 10-Q · filed 2021-05-05 | $3.69M derived: sum of 2 quarters · filed 2022-03-01 | -$8.35M derived: sum of 3 quarters · filed 2022-03-01 | -$29.69M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$17.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$29.37M derived: sum of 2 quarters · filed 2022-03-01 | -$50.71M derived: sum of 3 quarters · filed 2022-03-01 | -$69.09M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$12.04M 10-Q · filed 2020-11-05 | -$33.38M derived: sum of 2 quarters · filed 2020-11-05 | -$51.75M 10-Q · filed 2020-11-05 | -$49.22M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | -$21.34M 10-Q · filed 2020-08-04 | -$39.72M 10-Q · filed 2020-08-04 | -$37.19M derived: sum of 3 quarters · filed 2021-03-02 | -$61.55M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | -$18.38M 10-Q · filed 2020-05-05 | -$15.85M derived: sum of 2 quarters · filed 2021-03-02 | -$40.22M derived: sum of 3 quarters · filed 2021-03-02 | -$66.33M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | -$21.84M derived: sum of 2 quarters · filed 2021-03-02 | -$47.95M derived: sum of 3 quarters · filed 2021-03-02 | -$72.68M 10-K · filed 2021-03-02 |
| 2018-09-30 | -$24.37M 10-Q · filed 2019-11-05 | -$50.48M derived: sum of 2 quarters · filed 2019-11-05 | -$75.22M 10-Q · filed 2019-11-05 | -$101.43M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$26.11M 10-Q · filed 2019-08-06 | -$50.84M 10-Q · filed 2019-08-06 | -$77.06M derived: sum of 3 quarters · filed 2020-02-27 | -$94.92M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$24.73M 10-Q · filed 2019-05-07 | -$50.95M derived: sum of 2 quarters · filed 2020-02-27 | -$68.80M derived: sum of 3 quarters · filed 2020-02-27 | -$88.15M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$26.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$44.07M derived: sum of 2 quarters · filed 2020-02-27 | -$63.41M derived: sum of 3 quarters · filed 2020-02-27 | -$79.62M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$17.86M 10-Q · filed 2018-11-06 | -$37.20M derived: sum of 2 quarters · filed 2018-11-06 | -$53.40M 10-Q · filed 2018-11-06 | -$69.19M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$19.34M 10-Q · filed 2018-08-08 | -$35.55M 10-Q · filed 2018-08-08 | -$51.33M derived: sum of 3 quarters · filed 2019-02-28 | -$74.07M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$16.20M 10-Q · filed 2018-05-01 | -$31.99M derived: sum of 2 quarters · filed 2019-02-28 | -$54.73M derived: sum of 3 quarters · filed 2019-02-28 | -$68.38M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$38.53M derived: sum of 2 quarters · filed 2019-02-28 | -$52.17M derived: sum of 3 quarters · filed 2019-02-28 | -$69.74M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$22.74M 10-Q · filed 2017-11-07 | -$36.39M derived: sum of 2 quarters · filed 2017-11-07 | -$53.95M 10-Q · filed 2017-11-07 | -$66.70M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | -$13.65M 10-Q · filed 2017-08-01 | -$31.21M 10-Q · filed 2017-08-01 | -$43.96M derived: sum of 3 quarters · filed 2018-03-06 | -$50.74M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-03-31 | -$17.57M 10-Q · filed 2017-05-02 | -$30.31M derived: sum of 2 quarters · filed 2018-03-06 | -$37.09M derived: sum of 3 quarters · filed 2018-03-06 | -$51.07M derived: sum of 4 quarters · filed 2018-03-06 |
| 2015-12-31 | -$12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$19.53M derived: sum of 2 quarters · filed 2018-03-06 | -$33.50M derived: sum of 3 quarters · filed 2018-03-06 | -$51.74M 10-K · filed 2018-03-06 |
| 2015-09-30 | -$6.78M 10-Q · filed 2016-11-01 | -$20.75M derived: sum of 2 quarters · filed 2016-11-01 | -$39.00M 10-Q · filed 2016-11-01 | -$61.36M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | -$13.97M 10-Q · filed 2016-08-02 | -$32.22M 10-Q · filed 2016-08-02 | -$54.58M derived: sum of 3 quarters · filed 2017-03-07 | -$75.62M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | -$18.24M 10-Q · filed 2016-05-03 | -$40.61M derived: sum of 2 quarters · filed 2017-03-07 | -$61.65M derived: sum of 3 quarters · filed 2017-03-07 | -$87.11M derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | -$22.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | -$43.41M derived: sum of 2 quarters · filed 2017-03-07 | -$68.86M derived: sum of 3 quarters · filed 2017-03-07 | -$91.25M 10-K · filed 2017-03-07 |
| 2014-09-30 | -$21.04M 10-Q · filed 2015-11-03 | -$46.50M derived: sum of 2 quarters · filed 2015-11-03 | -$68.88M 10-Q · filed 2015-11-03 | -$85.83M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | -$25.46M 10-Q · filed 2015-08-04 | -$47.84M 10-Q · filed 2015-08-04 | -$64.78M derived: sum of 3 quarters · filed 2016-03-08 | -$88.72M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | -$22.39M 10-Q · filed 2015-05-07 | -$39.33M derived: sum of 2 quarters · filed 2016-03-08 | -$63.26M derived: sum of 3 quarters · filed 2016-03-08 | -$86.14M derived: sum of 4 quarters · filed 2016-03-08 |
| 2013-12-31 | -$16.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$40.87M derived: sum of 2 quarters · filed 2016-03-08 | -$63.76M derived: sum of 3 quarters · filed 2016-03-08 | -$89.47M 10-K · filed 2016-03-08 |
| 2013-09-30 | -$23.93M 10-Q · filed 2014-11-04 | -$46.81M derived: sum of 2 quarters · filed 2014-11-04 | -$72.53M 10-Q · filed 2014-11-04 | -$98.14M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | -$22.89M 10-Q · filed 2014-08-05 | -$48.59M 10-Q · filed 2014-08-05 | -$74.21M derived: sum of 3 quarters · filed 2015-03-03 | -$99.78M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | -$25.71M 10-Q · filed 2014-05-07 | -$51.33M derived: sum of 2 quarters · filed 2015-03-03 | -$76.89M derived: sum of 3 quarters · filed 2015-03-03 | -$101.78M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | -$25.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$51.19M derived: sum of 2 quarters · filed 2015-03-03 | -$76.07M derived: sum of 3 quarters · filed 2015-03-03 | -$99.38M 10-K · filed 2015-03-03 |
| 2012-09-30 | -$25.57M 10-Q · filed 2013-11-05 | -$50.45M derived: sum of 2 quarters · filed 2013-11-05 | -$73.76M 10-Q · filed 2013-11-05 | -$99.67M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | -$24.88M 10-Q · filed 2013-08-06 | -$48.19M 10-Q · filed 2013-08-06 | -$74.10M derived: sum of 3 quarters · filed 2014-03-04 | -$92.14M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | -$23.31M 10-Q · filed 2013-05-07 | -$49.22M derived: sum of 2 quarters · filed 2014-03-04 | -$67.26M derived: sum of 3 quarters · filed 2014-03-04 | -$88.82M derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-31 | -$25.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | -$43.95M derived: sum of 2 quarters · filed 2014-03-04 | -$65.51M derived: sum of 3 quarters · filed 2014-03-04 | -$86.37M 10-K · filed 2014-03-04 |
| 2011-09-30 | -$18.04M 10-Q · filed 2012-11-06 | -$39.60M derived: sum of 2 quarters · filed 2012-11-06 | -$60.46M 10-Q · filed 2012-11-06 | -$80.13M derived: sum of 4 quarters · filed 2013-03-05 |
| 2011-06-30 | -$21.56M 10-Q · filed 2012-08-07 | -$42.42M 10-Q · filed 2012-08-07 | -$62.09M derived: sum of 3 quarters · filed 2013-03-05 | -$11.73M derived: sum of 4 quarters · filed 2013-03-05 |
| 2011-03-31 | -$20.86M 10-Q · filed 2012-05-01 | -$40.53M derived: sum of 2 quarters · filed 2013-03-05 | $9.83M derived: sum of 3 quarters · filed 2013-03-05 | $36.81M derived: sum of 4 quarters · filed 2013-03-05 |
| 2010-12-31 | -$19.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $30.69M derived: sum of 2 quarters · filed 2013-03-05 | $57.67M derived: sum of 3 quarters · filed 2013-03-05 | $35.32M 10-K · filed 2013-03-05 |
| 2010-09-30 | $50.36M 10-Q · filed 2011-11-01 | $77.34M derived: sum of 2 quarters · filed 2011-11-01 | $54.99M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $26.98M 10-Q · filed 2011-08-02 | $4.63M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | -$112.04M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |